مشروع البحث:
Study the effect of Trastuzumab on cardiac function in the treatment of Libyan Human Epidermal Receptor-2 positive breast cancer patients.

dc.contributor.advisorد. منال موسي الهباش
dc.date.accessioned2024-12-04T08:34:19Z
dc.date.available2024-12-04T08:34:19Z
dc.descriptionObjective: This study was conducted to achieve three main aims: (i) evaluating the cardiac effect of trastuzumab use among Libyan HER-2 + BC patients in clinical practice. (ii) assessing the incidence of TIC and CHF. (iii) identifying the possible risk factors that could induce cardiotoxicity among Libyan breast cancer patients who used the studied intervention.
dc.description.abstractBackground: Breast cancer remains a pervasive global health concern, and its heterogenous nature calls for tailored therapeutic approaches. Trastuzumab, a monoclonal antibody targeting HER2, has revolutionized the treatment landscape for HER2+ BC patients. It significantly improves the patients' survival rates. However, a well-documented concern with trastuzumab is its potential to induce cardiotoxicity, which present a significant challenge in clinical management.
dc.identifier24151
dc.identifier.urihttps://dspace.academy.edu.ly/handle/123456789/500
dc.subjectfunction in the treatment
dc.titleStudy the effect of Trastuzumab on cardiac function in the treatment of Libyan Human Epidermal Receptor-2 positive breast cancer patients.
dspace.entity.typeProject
project.endDate2023
project.funder.nameالأحياء الدقيقة
project.investigatorأمل المرغني محمد
project.startDate2022
relation.isOrgUnitOfProject2a4bb5ff-48b1-4f80-b63a-91de3ccabeb4
relation.isOrgUnitOfProject.latestForDiscovery2a4bb5ff-48b1-4f80-b63a-91de3ccabeb4
الملفات
الحزمة الأصلية
يظهر اﻵن 1 - 1 من 1
لا توجد صورة مصغرة متاحة
اﻻسم:
breast cancer-V1.0.pdf
الحجم:
1.93 MB
التنسيق:
Adobe Portable Document Format
حزمة الترخيص
يظهر اﻵن 1 - 1 من 1
لا توجد صورة مصغرة متاحة
اﻻسم:
license.txt
الحجم:
1.71 KB
التنسيق:
Item-specific license agreed to upon submission
الوصف: